MetaxaloneThird Party Manufacturing in India

Metaxalone is a centrally acting skeletal muscle relaxant whose precise mechanism is not fully understood but is believed to involve depression of the central nervous system at the level of the brainstem and spinal cord. It does not act directly on skeletal muscle at the neuromuscular junction or on the muscle fibre itself. Instead, Metaxalone is thought to exert its effects by inhibiting polysynaptic reflexes in the spinal cord, reducing the transmission of nerve impulses that mediate muscle tone and spasm. This central depressant activity decreases the frequency and intensity of muscle contractions without impairing voluntary motor function at therapeutic doses. The drug also has sedative properties that contribute to its clinical effectiveness, as muscle spasm is often exacerbated by anxiety, stress, and pain perception. By reducing both the neural drive to muscles and the conscious perception of discomfort, Metaxalone helps break the pain-spasm-pain cycle that characterises acute musculoskeletal conditions. Unlike benzodiazepines, Metaxalone does not act on GABA-A receptors and has a different safety profile with lower potential for physical dependence. It is rapidly absorbed after oral administration, reaches peak plasma concentrations within three hours, and is extensively metabolised in the liver by cytochrome P450 enzymes, primarily CYP1A2 and CYP2D6.

Therapeutic Uses

Metaxalone is prescribed for the treatment of:

• Acute musculoskeletal pain associated with muscle spasm: Provides relief from painful muscle spasms due to strains, sprains, and other acute soft tissue injuries.
• Low back pain: Effective as an adjunct to rest and physical therapy for acute mechanical low back pain with muscle spasm.
• Whiplash and cervical sprain: Reduces neck muscle spasm and associated pain following hyperextension-flexion injuries.
• Fibromyalgia-related muscle tension: Used adjunctively to manage painful muscle tightness in fibromyalgia patients.
• Post-surgical muscle spasm: Helps manage involuntary muscle contraction following orthopaedic or spinal surgery.

Why Manufacturers Choose Metaxalone

Metaxalone is one of the most prescribed skeletal muscle relaxants in the United States and enjoys growing acceptance in international markets. It is available in a single 800 mg tablet strength, simplifying production and inventory management. The drug has a more favourable sedation profile compared to older muscle relaxants like cyclobenzaprine and carisoprodol, giving it a competitive edge. API is readily available from multiple Indian manufacturers, and the tablet formulation uses standard direct compression or wet granulation methods. The molecule is well-suited for both domestic Indian marketing and high-value export to the US (USP standards) and other regulated markets. This makes Metaxalone one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.